AMIX

Announcements

Nothing here yet

Daily updates

• Autonomix Medical secured a Canadian patent covering catheter-based transvascular instruments designed to access extravascular tissue. The patent expands international protection for its targeted nerve-ablation platform following U.S. and European approvals, while FDA pre-submission guidance identified a potential 510(k) pathway for its standalone transvascular sensing technology.Oct 2, 2026

FDA designations

Nothing here yet

News

• Autonomix Medical expands its global intellectual property portfolio with a European patent supporting its precision neuromodulation platformSep 25, 2026
• Autonomix Medical expanded its intellectual property portfolio with a new U.S. patent covering feedback-guided precision neuromodulation and targeted therapy deliveryAug 26, 2026
• Autonomix Medical completed a GLP preclinical study, marking a key step toward an FDA submissionAug 12, 2026
• Autonomix Medical received a U.S. patent for its overactive bladder diagnosis and treatment platformJul 15, 2026
• Autonomix Medical receives U.S. patent for transvascular monitoring and treatment systems with real-time procedural validationMay 19, 2026